• TGOD recently received its second organic certification at its Hamilton facility
• Jefferies and Seaport Global have initiated coverage on the company’s stock
• TGOD’s Canada-listed shares climbed by more than 19 percent between February 28 and March 28, 2019
• Company has received initial approval to operate a cannabis greenhouse in Ancaster, Ontario

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is now most definitely on the radar of the investment community. In February, NYC-based investment bank Jefferies initiated coverage of the stock with a ‘Buy’ recommendation (http://ibn.fm/xdUNV). The company’s stock price has been climbing in the wake of this milestone. Coverage appears to have increased investor confidence, as has confirmation that the company continues to pursue its strategy of producing premium organic cannabis at low cost. TGOD has received organic certification from Pro-Cert Organic Systems Ltd. for its Hamilton facility, the second time it has done so.

Earlier, Seaport Global Securities’ Senior Equity Analyst initiated coverage on the company with a ‘Buy’ rating and a bullish price target, citing the company’s bright future in the consumer packaged goods (CPG) space.

Organic certification is a big deal for TGOD, big enough for the company to enshrine the concept in its name. Organic cultivation leads to a cleaner product – one free of synthetic fertilizers and pesticides, which can pervert natural growth processes. In May 2018, TGOD’s facility based in Ancaster, Ontario, received organic certification from Ecocert Canada, an internationally recognized world-leading organization in organic certification. Ecocert is one of the most discerning organic certification bodies, with standards that are based on employing natural and organic cultivation principles, including the use of ingredients derived from renewable resources and environmentally-friendly processes.

The new certification from Pro-Cert marks a doubling down by TGOD on the production of clean cannabis (http://ibn.fm/EcUv0). The certifier of organic, gluten-free and grass-fed products is one of North America’s premier certification bodies, with a client base of producers, processors and traders stretching across Canada and the United States. Pro-Cert’s certification programs are ISO 17065-compliant and accredited, providing global recognition and international access to the products that are certified. Certified brands and products carry the Pro-Cert logo.

“Organic” is a label that refers to methods of agricultural production and food processing designed to minimize disruption of the natural environment, encourage the health and vitality of the soil, promote humane animal management and preserve ecological integrity. To use the label, manufacturers and producers must typically comply with government regulations. For example, the U.S. Department of Agriculture has four distinct labeling categories for certified organic food products: ‘100% Organic’, ‘Organic’, ‘Made with Organic ***’ (http://ibn.fm/QyiQp) and ‘Specific Organic Ingredients’. Generally, organic standards prohibit the use of synthetic pesticides, synthetic fertilizers, synthetic hormones, genetic engineering, sewage sludge and irradiation during crop production. These standards also forbid artificial food colors, flavors and sweeteners, as well as many preservatives and processing aids.

Canadian consumers have stated a preference for organic cannabis. In a recent study conducted by Hill & Knowlton, over 50 percent of recreational consumers stated that it was important that their cannabis be organic. When the same question was posed to medical patients, that number increased to 63 percent.

In addition, TGOD recently received news that the Hamilton City Council has voted to approve the company’s settlement offer, allowing TGOD to operate its cannabis greenhouse in Ancaster, Ontario, upon confirmation of the settlement by the Local Planning Appeal Tribunal at a meeting scheduled for April 25, 2019. According to the press release (http://ibn.fm/sPj23), the combined facilities in Ancaster, when complete, will be capable of growing 17,500 kgs of organic cannabis annually. The newly constructed, LEED-designed purpose-built greenhouse is expected to commence growing operations by June and employ up to 85 people. In a news release, Brian Athaide, CEO of TGOD, stated, “This is important to TGOD’s ability to generate considerable near-term revenue while the Company continues to approach its global planned output of 219,000 kgs.”

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• The new CBD oil product was introduced at the Financial Carnival Event in San Francisco
• The full-spectrum oil joins CIIX’s other CBD products, including OptHemp and the OPT2Mist CBD-infused sprays
• CEO sees possibility of reaching $6-$10 million in annual sales volume, facilitating uplisting to the New York Stock Exchange or the Nasdaq Capital Market

ChineseInvestors.com Inc. (OTCQB: CIIX) has added a high-end, full-spectrum brand of CBD oil to its CBD offerings through subsidiary ChineseHempOil.com Inc. The new product line is available at www.365CWC.com. CIIX said in a news release that the new, branded oil should have a positive impact on its sales and profit margin (http://ibn.fm/EbzcF).

CIIX’s new site, which caters to both Chinese and English speakers, offers a growing selection of CBD wellness products, including:

• OPTHemp-branded organic, industrial hemp-derived CBD oil, CBD scrub and cream and other hemp-infused cosmetics;
• OPT2Mist daily vitamin and full-spectrum CBD-infused sprays; and
• Organic full-spectrum CBD oil sourced from Colorado.

In a news release (http://ibn.fm/hcvXw), CIIX CEO Warren Wang said, “This 100 percent organic product, free of pesticides, herbicides and chemical fertilizers, will provide our most discerning, health-conscious customers with one of the highest quality CBD oils available.” The CBD oil was introduced in San Francisco at the Financial Carnival Event, Wang added.

In an interview on MoneyTV with Donald Baillargeon, Wang expressed hopes that, within the next three to five years, the company will be uplisted to the New York Stock Exchange or the Nasdaq Capital Market as it reaches up to $10 million in annual sales volume (http://ibn.fm/15XKN).

Based in San Gabriel, California, CIIX offers educational programs in investing to its international Chinese-speaking audience. The company also offers an industrial hemp-infused consumer products line.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• Therma Bright Inc.’s proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration
• The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to see continued growth
• The company is waiting on regulatory approvals for its thermal therapy technology, which incorporates the use of cannabis or cannabidiol

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical (the convergence of cosmetic and pharmaceutical products) industry, offers relief for insect and marine life bites and stings, which is especially relevant as spring weather patterns transition into increasingly wet and humid conditions.

The company’s pain-free skin care offerings alleviate pain, itch and discomfort caused by a myriad of creatures, including bees, wasps, hornets, mosquitos, black flies and jellyfish. Therma Bright’s products, devices and treatments are effective and non-invasive, offering both cosmetic and medicinal or therapeutic benefits. This proprietary technology has received Class II medical device status from the U.S. Food and Drug Administration.

The global market for cosmeceuticals was valued at nearly $47 billion in 2017 and is estimated to be worth more than $80 billion by 2023. The industry is growing at a rate of nearly 9.5 percent, according to a report published by Mordor Intelligence (http://ibn.fm/8VK8q). Many factors are contributing to this growth, including a “sustained rise in aging population globally.” As the life expectancy for both women and men increases, the share of people over 75 using cosmetics is also on the rise. Women and men are desirous of maintaining a youthful appearance, and this healthy demand for such cosmetic products has opened a window for innovation. The industry continues to thrive as a result of these factors.

Currently, Therma Bright is utilizing social media to market its products, working to develop and maintain relationships with established North American and global retailers. In an effort to enter the flourishing cannabis market, Therma Bright is also researching methods of utilizing medical grade cannabis or cannabidiol (CBD) to achieve back, knee and other joint pain relief. Once it obtains the proper regulatory approvals, the company plans to use its wholly owned subsidiary to produce and sell its thermal therapy technology, which incorporates medical cannabis.

For more information, visit the company’s website at www.ThermaBright.com

NOTE TO INVESTORS: The latest news and updates relating to THRBF are available in the company’s newsroom at http://ibn.fm/THRBF

• Most of MCOA’s projects involve the cultivation and distribution of hemp-derived products
• The company has officially launched its industrial hemp-based, CBD-formulated hempSMART products in the United Kingdom
• MCOA recently entered into an LOI with Natural Plant Extracts of California

An umbrella company, Marijuana Company of America Inc. (OTCQB: MCOA) supports an array of portfolio businesses that participate in the cannabis industry. Primarily an industrial hemp business, MCOA’s hempSMART company is focused on producing premier-quality botanical supplements derived from organically grown industrial hemp and synergistic botanicals (http://ibn.fm/jL0vQ). MCOA is headquartered in Escondido, California.

Fundamentally, hempSMART offers a line of industrial hemp-derived cannabidiol (non-THC) products. The expectation is that the hemp market will increase tenfold this year. Hemp acreage in the United States increased by more than 500 percent between 2015 and 2017. Some estimates declare that 70 percent of the U.S. hemp crop is grown for cannabidiol (CBD) (http://ibn.fm/9eFoZ).

In the United States, MCOA is raising the profile of its hempSMART subsidiary. In addition, the company is planning an expansion of the brand into Asia and Europe (http://ibn.fm/NTkAg). hempSMART also offers the opportunity to distribute its products as part of its affiliate network marketing program. This program centers on promoting and selling the company’s legal hemp-based consumer products containing CBD.

hempSMART officially launched MCOA’s industrial hemp-based, CBD-formulated hempSMART products in the United Kingdom during the company’s March 23, 2019, launch event in London (http://ibn.fm/2ZYcw). Its launch program included an in-depth overview of the CBD industry, its hempSMART products and marketing and compensation plans, which also feature information on how associates can start their own businesses in the CBD industry.

In a news release, MCOA Chief Executive Officer Donald Steinberg said, “We are now ready to start on the global rollout of our hempSMART products. Our software is set to accommodate many countries, our product line has been well developed, and we have leaders throughout the world ready to take up their roles as county directors.”

MCOA recently announced that it has entered into a letter of intent (LOI) with Natural Plant Extracts of California (“NPE”) and its subsidiary, Northern Lights Distribution LLC (“NLD”). This LOI is to acquire a 20-percent ownership interest in NPE and also to establish a joint venture (JV) to operate a California cannabis delivery service called Viva Buds.

Through the JV with NPE’s distribution company, MCOA created the wholly owned subsidiary Viva Buds Inc. to serve as the marketing division for NLD’s new retail delivery service in California. MCOA will first concentrate on delivering cannabis products to Southern California and subsequently launch to other cities across the state (http://ibn.fm/5WuTO).

Steinberg added, “This partnership will enable MCOA to establish itself as a major player in the cannabis arena. All licenses are in place to allow for vertical integration from farm to consumer. We are excited to expand our business model to now include marketing our new THC brand Viva Buds through our fully licensed partner NPE.”

Providing first-rate turnkey services to the legal cannabis and hemp industry, MCOA continues to advance its initiatives. The company offers investors the opportunity to partake in an industry that is showing exponential growth. MCOA has established itself along different points in the industrial hemp, cannabis and related services supply chain as it works to create even more value for its shareholders.

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• THRBF offers an IoT- and Bluetooth-enabled device for cold-sore prevention
• Its sales strategy is part of the company’s larger focus on developing products for the dermatology market
• THRBF’s proprietary technology is designed to prevent cold sores in the OTC sector, which is projected to record significant sales growth

Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) is offering a new generation of technology in the burgeoning skin care market. The company is specifically planning to target sales growth for its high gross-margin InterceptCS* cold sore prevention device with a new website, social media campaign and online sales strategy (http://ibn.fm/qqEgF).

THRBF’s new InterceptCS is a class II medical device that works through three 30-second treatments and offers multi-use activators. Therma Bright’s strategy is to market the product online through distributors and a new social media campaign, as well as on its new website at www.ColdSores.com.

Toronto-based THRBF offers first-rate medical devices for dermatological needs. The company focuses on proprietary technology in the OTC pain-free and noninvasive sectors, and it has received class II medical device status from the U.S. Food and Drug Administration (FDA). Therma Bright also markets TherOZap, an insect-bite treatment device.

The dermatology market is estimated to reach $22.6 billion in the United States by 2028, according to GMR Data (http://ibn.fm/tzY4X).

* Based on a double-blind placebo study, InterceptCS is approved for the claim, “For prevention of cold sores when used within three hours of the onset of the prodrome,” by Health Canada. InterceptCS is not approved by the United States FDA for any claim of clinical indication, clinical efficac, and/or cure or prevention of disease.

For more information, visit the company’s website at www.ThermaBright.com

NOTE TO INVESTORS: The latest news and updates relating to THRBF are available in the company’s newsroom at http://ibn.fm/THRBF

• The R&D program will focus on the proprietary Lexaria DehydraTECH delivery technology with the purpose of enhancing it further
• Results could contribute to new patent filings in the future; in addition, the program will examine more extensively the way DehydraTECH-enabled CBD outperforms generic CBD
• Lexaria-designed nanotech enhancements will also be included in the program

Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is launching its largest cannabinoid research and development program to date. The program consists of 11 separate animal studies, according to a company press release (http://ibn.fm/xidEM).

The Lexaria in vitro study design was conceptualized six months ago. Laboratory test articles have been produced and meet or exceed required quality control thresholds. The program has moved on to the implementation stage, which includes testing for a variety of performance-enhancing variations of the company’s DehydraTECH.

The DehydraTECH trademarked delivery technology is patented for cannabidiol (CBD) and tetrahydrocannabinoid (THC). The technology has a wide scope of applications, with evidence gathered separately of an ability to cross the blood-brain barrier, which could lead to applications related to nervous system conditions like Alzheimer’s disease.

Through the research, Lexaria aims to enhance the DehydraTECH drug delivery platform even further, with optimization enhancement designed to improve the platform’s performance in next-generation formulations currently under development.

As per the official Lexaria announcement, the research and development program could contribute to additional patent filings in the future. Thus, the company has limited information about the study’s design for the time being. The primary aim of the research, however, is to determine the mechanisms by which DehydraTECH-enabled CBD outperforms generic CBD – a fact that has already been established through multiple trials.

DehydraTECH and the other Lexaria technologies are already disrupting the cannabis edibles industry. These developments reduce the undesirable taste of CBD products, eliminate the need for the addition of sweeteners (simplifying the creation of sugar-free options), increase absorption rates and reduce the time of positive effect onset.

Lexaria-designed nanotech enhancements will also be included among the research and development program subjects. In the beginning of 2018, Lexaria evaluated a number of nanotech emulsions for use with DehydraTECH. These nano emulsions are expected to be tested in combination with the DehydraTECH delivery system for the first time ever.

Various nanotech solutions are already available on the market. No other company, however, has come up with a combination of nano emulsions and a drug delivery platform that’s patented for use with cannabinoids. Lexaria representatives believe that the combination enhances the individual performance characteristics of both technologies.

DehydraTECH is a disruptive delivery technology platform that promotes healthier ingestion methods and lower dosages, while increasing overall effectiveness of lipophilic active molecules. Lexaria Bioscience Corp. has multiple patents pending in over 40 countries and already has patents granted in the U.S. and Australia for the utilization of its signature DehydraTECH technology. The technology increases intestinal absorption rates, allowing for more rapid delivery to the bloodstream of various orally administered bioactive compounds, such as cannabinoids, vitamins and non-steroid anti-inflammatory drugs.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Marijuana Company of America Inc. recently initiated a new push into tetrahydrocannabinol (THC) product development through an LOI with Natural Plant Extract of California
• Analysts predict that California’s cannabis market will reach $5.1 billion in sales this year and $7.7 billion by 2022
• Recreational use marijuana is expected to be the prime driver in the market

During a crucial year for expansion in California’s cannabis market, Marijuana Company of America Inc. (OTCQB: MCOA) is lighting the pathway toward achieving its goal of farm-to-consumer vertical collaboration among its subsidiaries in the cannabis space.

MCOA recently uplisted its trading tier to the OTCQB Venture Marketplace, as well as improving its hempSMART brand presence as cannabidiol (CBD) oils and infused products gain increasing gravitas among the health and wellness community.

This month, the company added a push into the tetrahydrocannabinol (THC) product space by announcing an LOI with Natural Plant Extract of California (“NPE”) and its subsidiary, Northern Lights Distribution, LLC, to establish a joint venture that would operate a California cannabis delivery service named Viva Buds.

“This partnership will enable MCOA to establish itself as a major player in the Cannabis arena,” CEO Donald Steinberg stated in a news release about the agreement (http://ibn.fm/UZuHW). “The NPE team has a great deal of industry knowledge and has an industry disruptive business model. This is a huge strategic move for MCOA!”

Although California is more than a year into its legalization of recreational marijuana use, regulatory differences between the state’s local community markets can make getting cannabis products to consumers challenging. At the same time, the ongoing federal view of cannabis as a restricted plant has limited transportation contracts to companies that don’t have federal contracts, leaving the door open to potential competition in the space such as the proposed Viva Buds delivery service.

Data analysts at industry advisory firm Cannabis Business Plan are forecasting a California cannabis market with $7.7 billion in annual sales by 2022, with 61.5 percent of the overall market driven by recreational use marijuana (http://ibn.fm/KMTNr). Researchers at BDS Analytics predict that sales of cannabis will hit $5.1 billion in California this year due to the fast-moving nature of what is one of the largest cannabis markets in the world (http://ibn.fm/SjxCl). California tax and fee regulators are already celebrating the nearly $350 million in sales and excise tax receipts brought in during the first year of recreational marijuana legalization in the state, even though expectations had been for almost double that amount (http://ibn.fm/ED7tE).

Marijuana Company of America has seen its expectations for a cannabis boom enhanced by regulatory changes in the United States, such as the passage of the 2018 Farm Bill just ahead of year’s end, which allowed hemp to be classified as an agricultural product and paved the way for it to become a farm commodity largely free of drug schedule restrictions, even though components of the plant used for medicinal purposes still have to abide by Food and Drug Administration standards to be approved (http://ibn.fm/pORXr).

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• Sales grew by more than $64 million since December 2017 launch of products
• SHRV CEO credits ‘Blue Ocean Strategy’, along with Elepreneur and Elevacity Global subsidiaries, for record performance
• Name change reflects company’s international growth strategy

Sharing Services Global Corporation (OTCQB: SHRV) reported sales of $25.9 million for its fiscal Q3 2018 ended January 31, 2019. Those numbers are $8 million higher than the $17.9 million in revenue reported in the previous quarter (http://ibn.fm/yflX1). SHRV CEO John “JT” Thatch said that the increase was due in part to the company’s implementation of a ‘Blue Ocean Strategy’ in its direct selling market. The company also announced that it has changed its name to Sharing Services Global Corporation to better reflect its international growth strategy (http://ibn.fm/YXZDY).

“Our 2018 Q3 results are continued proof that our ‘Blue Ocean Strategy’ is being implemented and accepted in the direct-selling marketplace,” Thatch said in a news release (http://ibn.fm/07NBw). “At a record-breaking pace, our Elepreneur division continues to execute on our mission to change the direct-selling industry with best-in-class products and services.” SHRV sales have grown by more than $64 million since the December 2017 launch of products through its Elepreneur and Elevacity Global divisions.

SHRV is a Plano, Texas-based diversified holdings company that owns, operates or controls a variety of companies engaged in direct selling through independent sales representatives. It also offers services such as energy, technology and insurance. Its divisions include Elevacity Global LLC and Elepreneur LLC.

In a 14A SEC filing, SHRV said that its recent name change would more accurately reflect the company’s international expansion moves (http://ibn.fm/ChZIB). The company said in the filing that it was planning to grow both organically and by making strategic acquisitions of businesses and technologies. “The company believes there are excellent growth opportunities outside the United States, including in Canada, Mexico, Europe and Asia,” the filing reads.

For more information, visit the company’s website at www.SHRVInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRV are available in the company’s newsroom at http://ibn.fm/SHRV

• 7ACRES cultivation facility’s increase in space set to grow production capacity by 50 percent, reaching approximately 26,250 kg
• BMO Capital Market analysts initiated coverage of The Supreme Cannabis Company at Market Perform
• The company is set to launch its line of premium cannabis oil products in April 2019

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading company in the cannabis industry that’s committed to providing premium brands and products, is seeking to grow the world’s best cannabis and become a leader in the global industry. As legalization spreads around the world, the cannabis industry continues to evolve from a market once limited to illicit recreational activity into one marked by innovative products utilized for myriad purposes, including medicinal, pharmaceutical, and health and wellness applications. Investors are realizing the lucrative potential of cannabis products, and companies such as The Supreme Cannabis Company are poised to become industry leaders.

Recently BMO Capital Markets analysts Tamy Chen, CFA, and Peter Sklar, CPA, initiated coverage of The Supreme Cannabis Company at Market Perform. This included a C$2.50 per share price target, which represented a 15 percent premium to the then-current market price. Given more brand development, the analysts anticipate a potential C$3.00 share price (http://ibn.fm/b75iI), especially with “accelerating sales, ramping production, and strategic international acquisitions.”

The Supreme Cannabis Company anticipates reaching multiple milestones this year. As of March 2019, the company has amassed growing room space of 180,000 square feet at its 7ACRES cultivation facility. This growth will enable production capacity to increase by 50 percent, reaching approximately 26,250 kg (http://ibn.fm/79ykL). Additionally, supply agreements are in place throughout eight Canadian provinces. As such, the company’s target goals continue to increase to match its evolving production capacity, which could potentially reach approximately 50,000 kg in the near future.

Supreme Cannabis president and founder John Fowler noted the significance of the company’s increased facility square footage. He described (http://ibn.fm/j0YeB) the expansion as “a major milestone, which represents a 50 percent increase in our estimated annual production capacity. With 18 of 25 flowering rooms at 7ACRES now approved by Health Canada, production space at our facility is near the finish line.” Noting the availability of the company’s 7ACRES brand in eight of 10 Canadian provinces, Fowler stated that he looks forward to serving “what [company leaders] believe to be the highest quality cannabis grown at scale in the country.”

In another step to increase its industry presence, The Supreme Cannabis Company recently announced an anticipated launch of its previously detailed cannabis oil products. These products are set to be released to the adult-use consumer market in select Canadian provinces beginning in April 2019. Each bottle of oil will contain the company’s proprietary blend of highly purified cannabis oils and terpenes harvested from plants grown by 7ACRES.

Supreme Cannabis CEO Navdeep Dhaliwal believes that the company’s focus on premium cannabis will deliver a superior cannabis oil experience. He added, “Our formulation will leverage super-critical CO2 technology to produce a high-quality, purified cannabis oil,” which is then re-formulated with the naturally occurring terpenes found in 7ACRES’ high-end cannabis. The resulting oil promises consumers a premium experience (http://ibn.fm/8GnDP).

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• Green Hygienics Holdings is planning to buy a San Diego-area ranch that occupies over 824 acres of flat grassland pasture
• The company is targeting the medical and recreational-use cannabis markets in California, which combine to make up the largest legal marketplace for cannabis sales
• GRYN anticipates that it could harvest 1,200 to 1,500 pounds of hemp per acre in two growing seasons each year

Premium cannabis cultivation company Green Hygienics Holdings Inc. (OTCQB: GRYN) announced on March 18 that it has opened escrow for the purchase of a ranch property near San Diego that will provide its growing operations with over 824 acres of flat, native grassland pasture sheltered by surrounding mountains (http://ibn.fm/ws21X).

The company is targeting the California medical and adult recreational-use markets for the plant whose growing popularity has driven changes in governmental drug-use policies on a global scale during recent years. California is the world’s largest marketplace for cannabis sales, although Canada’s nationwide full legalization of the plant last year is expected to eventually give it a boost over rivals during the next decade (http://ibn.fm/WaTXc).

Green Hygienics has a long-term strategy for expanding its portfolio throughout the United States and then advancing into the global arena, growing the company in size and revenues as it builds a large cultivation and extraction center in Canada. The company’s announcement about the potential for a cultivation site in Southern California heralds a major step toward its goals.

“Given that there is the potential to harvest 1,200 to 1,500 pounds of hemp per acre, we can produce two crops per year, and the price of hemp is at an average of $50 dollars per pound, this initiative has the potential to produce significant revenues for the Company,” Vice President of Business Development Matt Dole stated in the news release announcing the planned purchase. “This will also provide a base of operations for several other equally exciting initiatives. We have been working on this property acquisition for a very long time and are excited about the possibilities it opens up for the Company.”

The Potrero Ranch property includes 294,000 square feet of outbuildings that have been constructed on a concrete slab with triple phase power, water and gas services that make the structures ideal for use as greenhouses or storage, according to the company. The main building has a large built-in cooler, as well.

The land has an abundant water supply and the soil’s pH, as well as the altitude of the property, make the site “ideal for hemp cultivation,” the news release states.

As competition in the legal cannabis space increases among publicly-backed companies, GRYN believes that the future of commercial-sized plant cultivation for both hemp and cannabis hinges on using science to control the growing environment in order to deliver premium grades of product on a consistent basis at a comparatively low price.

For more information, visit the company’s website at www.GreenHygienicsHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN